Subcutaneous injection · Intranasal · Oral (bioavailability not established)
Half-life
Short — tripeptide; effects via gene regulatory interactions in brain tissue
Most studied use
Neuroprotection · Cognitive aging · Circadian rhythm support · Antioxidant brain protection · Longevity stack with Epithalon
Regulatory status
Not FDA-approved · Research chemical · Same status as Epithalon · Used in Russian clinical practice
Human evidence
Limited — Russian clinical studies primarily from Khavinson group; no Western RCTs
Preclinical evidence
Moderate — neuroprotective, antioxidant, and circadian effects in multiple animal models
EDUCATIONAL TOOL — NOT MEDICAL ADVICE
What is Pinealon?
Pinealon is the brain-specific companion to Epithalon in the Khavinson group's peptide bioregulator series. Where Epithalon (AEDG) targets systemic aging through telomerase activation and pineal gland regulation broadly, Pinealon (EDR) is specifically a brain and nervous system bioregulator — derived from pineal gland tissue but directed at neural tissue protection, cognitive function, and brain antioxidant defense.
The Khavinson group at the Saint Petersburg Institute of Bioregulation and Gerontology has developed a systematic library of short peptide bioregulators derived from different organs — thymus (Vilon, Thymalin), pineal gland (Epithalon, Pinealon), blood vessels (Vesugen), bone marrow (Bonomarlot), and others. Each is proposed to exert tissue-specific regulatory effects on the organ from which it's derived. Pinealon's specificity for brain tissue is the theoretical basis for its cognitive and neuroprotective applications.
For biohackers, Pinealon and Epithalon are typically used together as a longevity stack: Epithalon for systemic telomere maintenance and broad anti-aging effects, Pinealon specifically for brain and nervous system protection. The evidence base has the same single-group limitation as Epithalon — primarily from the Khavinson research program with limited independent replication. The evidence is meaningful within that context; it is not equivalent to Western-standard multicenter RCTs.
How it works
Brain Tissue-Specific Bioregulation
Pinealon (EDR tripeptide) is proposed to interact with regulatory sequences in brain tissue gene promoters — the Khavinson group's broader theory for short peptide bioregulators is that they regulate gene expression in a tissue-specific manner by interacting with chromatin and transcription factors. In brain tissue specifically, Pinealon is proposed to regulate genes involved in neuronal survival, antioxidant defense, and synaptic function. The exact molecular target is less well-characterized than CNTF pathway (P21) or BDNF pathway (Semax).
Antioxidant Protection
Pinealon reduces oxidative stress markers in brain tissue — upregulating SOD (superoxide dismutase) and catalase, reducing lipid peroxidation. The brain is particularly vulnerable to oxidative damage due to its high metabolic rate and oxygen consumption; antioxidant protection of neural tissue is mechanistically important for cognitive aging and longevity.
Neuroprotection Against Hypoxia and Ischemia
In animal models of cerebral hypoxia and ischemia, Pinealon reduces neuronal death, preserves cognitive function post-ischemia, and improves recovery. This neuroprotective mechanism — whether via antioxidant effects, anti-apoptotic signaling, or gene regulation — is consistent across the preclinical literature.
Circadian and Sleep Support
As a pineal gland-derived peptide, Pinealon influences circadian regulation and melatonin production patterns — similar to Epithalon but with stronger CNS specificity. Improved sleep quality and circadian rhythm support are consistent community and clinical reports, and align mechanistically with the pineal gland origin of the compound.
What the research shows
NOTE — PRIMARILY FROM KHAVINSON GROUP; SAME SINGLE-GROUP LIMITATION AS EPITHALON
STUDYAdvances in Gerontology · 2012
Pinealon improves cognitive function and quality of life in elderly patients
Khavinson VK et al.
Russian clinical study in elderly patients with cognitive impairment. Pinealon treatment improved cognitive performance scores and quality of life metrics vs. controls. Primary human evidence for Pinealon — from the developing group, Russian-language journal.
STUDYBulletin of Experimental Biology and Medicine · 2011
EDR peptide reduces neuronal apoptosis and oxidative stress in hypoxia
Khavinson VK et al.
Preclinical. Pinealon (EDR) reduced neuronal apoptosis and oxidative stress markers in brain tissue under hypoxic conditions. Establishes the neuroprotective and antioxidant mechanism.
✓Neuroprotection in hypoxia and ischemia animal models
✓Cognitive improvement in elderly patients — Russian clinical study
✓Circadian and sleep support consistent with pineal gland origin
?UNCERTAIN
?Exact molecular target and receptor mechanism
?Independent replication outside the Khavinson group
?Western-standard RCT data
?Optimal dosing and cycle structure for cognitive aging
What the community reports
—Improved sleep quality and depth — most consistently reported early effect; consistent with circadian/pineal mechanism; often noticed within the first week of a course
—Cognitive clarity — described as background improvement rather than acute sharpening; consistent with neuroprotective rather than neurostimulant mechanism
—Stacked invariably with Epithalon — the Epithalon + Pinealon combination is the standard Khavinson bioregulator stack; almost never used alone
—Same epistemic limitation awareness as Epithalon — users who run these compounds tend to have read the research and calibrated their confidence to the evidence quality
Common misconceptions
"Pinealon and Epithalon are interchangeable."
REALITY
Both are pineal gland-derived Khavinson peptides but different sequences with different proposed specificity. Epithalon (AEDG tetrapeptide) targets telomerase activation and systemic aging broadly. Pinealon (EDR tripeptide) is the brain/nervous system-specific bioregulator. They're complementary, not the same compound.
"The Russian clinical evidence equals Western RCT evidence."
REALITY
The Khavinson group's research is real published science, but lacks the methodological rigor, sample sizes, and independent replication of Western-standard multicenter RCTs. The evidence is meaningful — not equivalent to a large placebo-controlled trial. Calibrate confidence accordingly.
LONGEVITY BRAIN STACK — LAYERED MECHANISMS
Pinealon: CNS-specific neuroprotection + antioxidant + circadian. Epithalon: systemic anti-aging, telomerase activation, broad pineal regulation. Semax: acute BDNF upregulation and cognitive sharpening. Cerebrolysin: broadest neuroprotection with the most clinical evidence.
RECONSTITUTION CALCULATOR
EDUCATIONAL TOOL — NOT MEDICAL ADVICE · VERIFY WITH YOUR CLINICIAN
AI COACH PREVIEW
I'm running Epithalon. Should I add Pinealon and how do they differ?
Adding Pinealon to an Epithalon course is a mechanistically rational decision — let me explain why, and what to expect from each. What Epithalon is doing: telomere protection via telomerase activation, broad pineal gland regulation, systemic anti-aging effects. The evidence is concentrated in lifespan extension and circadian restoration. What Pinealon adds that Epithalon doesn't: brain-specific neuroprotection. Epithalon covers the systemic aging and pineal aspects broadly. Pinealon is proposed to specifically target brain and nervous system tissue — upregulating antioxidant enzymes (SOD, catalase), protecting neurons from hypoxic damage, and supporting cognitive function in aging. They're the same origin (pineal gland, Khavinson group) but different sequences with different tissue targets. The combination gives you: systemic anti-aging (Epithalon) + CNS-specific neuroprotection (Pinealon). Same cycle structure — both run 10-20 days daily SC, 2-4 times per year. Run them simultaneously rather than in separate cycles for simplicity. Timing: evening — aligns with circadian/pineal biology and overnight neural repair. What to track when adding Pinealon: sleep quality is the most reliable early signal. Most users notice sleep depth improvement within the first week. Track it nightly on a simple scale. Cognitive function — consistent daily metric if you want to capture that. General wellbeing and energy weekly. The epistemic calibration: Pinealon's evidence is from the same Khavinson group as Epithalon — compelling enough to explore, not proven by Western RCT standards. Same confidence level as Epithalon. What cycle of Epithalon are you on — first, or have you run it before?
CONTINUE IN THE APP
Open PepperLedger to track your Pinealon protocol →
Free to join. No credit card. Ask the Coach about your longevity peptide stack once you're in.
Free to join · No credit card · 23-day Pro trial included